Improving HIV treatment for young adults using technology and tailored support
Comprehensive, tailored, technology-based intervention to improve virologic suppression among youth and young adults living with HIV
This study is looking to improve care for young people aged 18 to 29 living with HIV by using technology to provide weekly counseling and support, helping them stick to their treatment while also addressing mental health and substance use challenges.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California, San Francisco NIH-funded |
| Lab location | 1 site (San Francisco, United States) |
| Project ID | NIH-10893368 on NIH RePORTER |
What this research studies
This research focuses on enhancing the treatment and care of youth and young adults living with HIV by addressing barriers such as mental health and substance use issues. It employs a technology-based intervention that includes weekly counseling sessions and personalized support to improve adherence to antiretroviral therapy. The study will involve a randomized clinical trial with 200 participants aged 18 to 29, aiming to create a more accessible and effective care model for this age group. By collaborating with the AIDS Healthcare Foundation and a Youth Advisory Panel, the research seeks to ensure that the intervention is youth-friendly and meets the specific needs of participants.
Who could benefit from this research
Good fit: Ideal candidates for this research are youth and young adults aged 18 to 29 who are living with HIV and facing challenges in accessing or adhering to treatment.
Not a fit: Patients outside the age range of 18 to 29 or those not living with HIV may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could significantly improve virologic suppression rates and overall health outcomes for young adults living with HIV.
How similar studies have performed: Previous research has shown success in using technology-based interventions to improve health outcomes in similar populations, indicating a promising approach.
Where this research is happening
San Francisco, United States
- University of California, San Francisco — San Francisco, United States (Active)
Researchers
- Principal investigator: Saberi, Parya — University of California, San Francisco
- Study coordinator: Saberi, Parya
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.